The trend of drug abuse in Taiwan during the years 1999 to 2011

Journal of Food and Drug Analysis

Volumn 21, Issue 4, 2013, Pages 390-396

  Lee, Shu Fen ^a   Hsu, Jui ^a   Tsay, Wen Ing ^a  

^a Executive Yuan   (Taiwan)

Author keywords

Designer drugs; Drug abuse; Trends

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABINOID; CHLORAMPHETAMINE; CODEINE; DESIGNER DRUG; DIAMORPHINE; ILLICIT DRUG; KETAMINE; METHAMPHETAMINE; MORPHINE; PHENYLALKYLAMINE; PIPERAZINE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ARTICLE; DRUG ABUSE; DRUG USE; HUMAN; METHAMPHETAMINE DEPENDENCE; MULTIPLE DRUG ABUSE; STATISTICS; TAIWAN; URINALYSIS;

EID: 84895923196     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfda.2013.09.003     Document Type: Article

References (28)

1. United Nations Office on Drugs and Crime (UNODC). World drug report 2012. United Nations, New York; June 2012.
2. Food and Drug Administration. National health interview and drug abuse survey. Taipei, Taiwan: Food and Drug Administration, Department of Health; 2009.
3. Lua AC, Lin BF, Tseng YT, et al. Drugs of abuse pattern in Taiwan. J Food Drug Anal 2002;10:69-74. (Pubitemid 34578266)
4. Liu C, Li JH, Tsay WI, et al. Drug use and profile of individuals arrested on drug-related charges in Taiwan. J Food Drug Anal 2005;13:101-6.
5. Strom KJ, Wong L, Fornnarino L, et al. The national forensic laboratory Information system: 2002 annual report. Washington: Drug Enforcement Administration, Washington, D. C.; 2003.
6. Standridge JB, Adams SM, Zotos AP. Urine drug screening: a valuable office procedure. Am Fam Physician 2010;81:635-40.
7. Konstantinova SV, Normann PT, Arnestad M, et al. Morphine to codeine concentration ratio in blood and urine as a marker of illicit heroin use in forensic autopsy samples. Forensic Sci Int 2012;217:216-21.
8. Li JH. Evolution of the legislative and administrative system of controlled drugs in Taiwan. J Food Drug Anal 2012;20:778-85.
9. Ng SH, Tse ML, Ng HW, et al. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J 2010;16:6-11.
10. National Police Agency, Ministry of the Interior, Republic of China. The statistics of the significant objective. http://www.npa.gov. tw/NPAGip/wSite/np?ctNode=12552&mp=1; 2012 [accessed 23.01.13]
11. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). EMCDDA-Europol 2011 Annual Report on the implementation of Council Decision 2005/387/JHA. EMCDDA; 2011.
12. Coppola M, Mondola R. Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food". Toxicol Lett 2012;211:144-9.
13. European Commission. Commission Staff Working Paper. http://ec.europa.eu/ justice/policies/drugs/docs/sec-2011-912-en.pdf [accessed 23.01.13]
14. Wohlfarth A, Weinmann W. Bioanalysis of new designer drugs. Bioanalysis 2010;2:965-79.
15. Cimbura G. PMA deaths in Ontario. Can Med Assoc J 1974;110:1263-7.
16. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Risk Assessments. Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs. Luxembourg: EMCDDA; 2003.
17. Zaitsu K, Katagi M, Kamata T, et al. Determination of a newly encountered designer drug "p-methoxyethylamphetamine" and its metabolites in human urine and blood. Forensic Sci Int 2008;177:77-84.
18. Lin DL, Liu HC, Yin HL. Recent paramet hoxymet hamphetamine (PMMA) deaths in Taiwan. J Anal Toxicol 2007;31:109-13.
19. Ragan FA, Hite SA, Samuels MS, et al. 4-Bromo-2, 5- dimethoxyphenethylamine: identification of a new street drug. J Anal Toxicol 1985;9:91-3. (Pubitemid 15103612)
20. Owen JE. Psychopharmacological studies of some 1-(chlorophenyl)-2- aminopropanes. II. Effects on avoidance and discrimination behavior. J Pharm Sci 1963;52:684-8.
21. Rosner P, Quednow B, Girreser U, et al. Isomeric fluoromethoxy- phenylalkylamines: a new series of controlledsubstance analogues (designer drugs). Forensic Sci Int 2005;148:143-56. (Pubitemid 40082404)
22. Itzhak Y, Ali SF. Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs. Pharmacol Ther 2006;109:246-62. (Pubitemid 41740825)
23. Lin TC, Lin DL, Lua AC. Detection of p-chloroamphetamine in urine samples with mass spectrometry. J Anal Toxicol 2011;35:205-10.
24. Cousto von Hans, Eve, Berlin Rave. Ecstasy-Falsifikate mit 4-FA und m-CPP im Umlauf!. Pillenwarnung vom 18, http://www.eve-rave.net/abfahrer/download.sp? id=4600; January 2009 [accessed 23.01.13]
25. Das Saferparty, Ch-Team. Achtung 4 F-A verkauft als Ecstasy. http://www.saferparty.ch/download/file/4-Fluoramphetamin-Juni-2009.pdf; 2009 [accessed 23.01.13]
26. Camilleri A, Johnston MR, Brennan M, et al. Chemical analysis offour capsulescontaining thecontrolled substanceanalogues 4-methylmethcathinone, 2-fluoromethamphetamine, alphaphthalimidopropiophenone and N-ethylcathinone. Forensic Sci Int 2010;197:59-66.
27. Rust KY, Baumgartner MR, Dally AM, et al. Prevalence of new psychoactive substances: a retrospective study in hair. Drug Test Anal 2012;4:402-8.
28. de Boer D, Bosman IJ, Hidvégi E, et al. Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. Forensic Sci Int 2001;121:47-56. (Pubitemid 32758813)